uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapykatie8288Jun 23, 20220 min read
Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
Comments